Search for: "COPE v. COPE"
Results 361 - 380
of 911
Sorted by Relevance
|
Sort by Date
29 Dec 2023, 3:03 pm
See, e.g., McGrew v. [read post]
10 Jun 2009, 5:15 am
Centanni v. [read post]
21 Jun 2021, 7:23 pm
Brash v. [read post]
9 Oct 2014, 8:46 am
The only old relist we’re aware of from OT2013 is Cope v. [read post]
25 Jun 2015, 3:02 pm
With the Supreme Court’s much anticipated June 25, 2015 King v. [read post]
28 Jul 2018, 1:35 am
Grieving after Wrongful Death I’m Ed Smith, a Vacaville wrongful death lawyer. [read post]
10 Feb 2012, 7:23 am
Pecina v. [read post]
13 Aug 2013, 4:15 pm
But that ruling, in Marks v. [read post]
22 Nov 2013, 10:43 am
Sheehan v. [read post]
24 Jan 2016, 11:23 am
Prosecutors said they had no constitutional duty under Brady v. [read post]
27 Sep 2023, 2:53 pm
See Mayo v. [read post]
16 Sep 2020, 6:15 am
See Vera v. [read post]
8 Sep 2020, 4:45 pm
There's a lot to be said for Justice Streeter's partial dissent in this case. [read post]
30 Dec 2010, 9:10 am
The fact that MPAC was understaffed and unable to cope with a deluge of new condos on the market was no justification for using a two-stage assessment not expressly permitted by the Assessment Act, s.33(1). #5 -- Metropolitan Toronto Condominium Corporation No. 675 v. [read post]
14 Oct 2024, 6:24 am
National vaccine attorney Leah V. [read post]
17 Jun 2009, 3:02 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: US: Gene patenting debate continues: UCLA v USPTO (Patent Docs) (Patent Docs) (PatentlyBIOtech) (Patent Docs) (IP Watchdog) US: FTC issues highly anticipated report on follow-on biologics; report concludes that special legislative exclusivity incentives are largely unwarranted for innovators and generics (FDA Law Blog) (Patent Docs) (Patent… [read post]
17 Jun 2009, 3:02 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: US: Gene patenting debate continues: UCLA v USPTO (Patent Docs) (Patent Docs) (PatentlyBIOtech) (Patent Docs) (IP Watchdog) US: FTC issues highly anticipated report on follow-on biologics; report concludes that special legislative exclusivity incentives are largely unwarranted for innovators and generics (FDA Law Blog) (Patent Docs)… [read post]
28 Jan 2017, 12:57 pm
In Dahlquist v. [read post]
3 Aug 2012, 11:01 am
" State v. [read post]
